Tomatidine Targets ATF4-dependent Signaling and Induces Ferroptosis to Limit Pancreatic Cancer Progression
Overview
Authors
Affiliations
Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with high metastasis and therapeutic resistance. Activating transcription factor 4 (ATF4), a master regulator of cellular stress, is exploited by cancer cells to survive. Prior research and data reported provide evidence that high ATF4 expression correlates with worse overall survival in PDAC. Tomatidine, a natural steroidal alkaloid, is associated with inhibition of ATF4 signaling in multiple diseases. Here, we discovered that and tomatidine treatment of PDAC cells inhibits tumor growth. Tomatidine inhibited nuclear translocation of ATF4 and reduced the transcriptional binding of ATF4 with downstream promoters. Tomatidine enhanced gemcitabine chemosensitivity in 3D ECM-hydrogels and . Tomatidine treatment was associated with induction of ferroptosis signaling validated by increased lipid peroxidation, mitochondrial biogenesis, and decreased GPX4 expression in PDAC cells. This study highlights a possible therapeutic approach utilizing a plant-derived metabolite, tomatidine, to target ATF4 activity in PDAC.
Mechanisms and Therapeutic Potential of GPX4 in Pain Modulation.
Fan S, Wang K, Zhang T, Deng D, Shen J, Zhao B Pain Ther. 2024; 14(1):21-45.
PMID: 39503961 PMC: 11751247. DOI: 10.1007/s40122-024-00673-8.
Wu W, Wen F, Hu J, Li L Neuropsychiatr Dis Treat. 2024; 20:1969-1983.
PMID: 39430656 PMC: 11491069. DOI: 10.2147/NDT.S480782.
B3GNT5 is a novel marker correlated with malignant phenotype and poor outcome in pancreatic cancer.
Yao W, Wang Y, Zhang X, Lin Y iScience. 2024; 27(10):110889.
PMID: 39319269 PMC: 11421285. DOI: 10.1016/j.isci.2024.110889.
MMP9 drives ferroptosis by regulating GPX4 and iron signaling.
Gawargi F, Mishra P iScience. 2024; 27(9):110622.
PMID: 39252956 PMC: 11382059. DOI: 10.1016/j.isci.2024.110622.
Recent progress of ferroptosis in cancers and drug discovery.
Wang X, Ren X, Lin X, Li Q, Zhang Y, Deng J Asian J Pharm Sci. 2024; 19(4):100939.
PMID: 39246507 PMC: 11378902. DOI: 10.1016/j.ajps.2024.100939.